November 2025 Newsletter – Our most versatile solution 🤝 Your latest product formulation
Breaking news - One ingredient, many solutions! Our new VAS (versatile application solution) technology hit the market November 6th.
Hypertension is a predisposing factor for cardiovascular disease (CVD). Results of previous clinical trials on the effects of lycopene supplementation on blood pressure are inconsistent. This systematic review and meta-analysis of randomized trials with parallel or cross-over design was conducted to summarize the effects of lycopene supplementation on blood pressure (BP).
Breaking news - One ingredient, many solutions! Our new VAS (versatile application solution) technology hit the market November 6th.
BRANCHBURG, N.J., Oct. 29, 2025 /PRNewswire/ — Lycored, the global leader in naturally derived carotenoids for the food, beverage and dietary supplement market, is expanding its ingredient capabilities with the...
BEIJING and TEL AVIV, Israel, Oct. 22, 2025 /PRNewswire/ — ADAMA (SZSE: 000553), a global leader in crop protection, has announced the appointment of Dafna Cohen-Asher as Chief Executive Officer of Lycored,...
Interested in speaking directly with a member of our team?
Click below to get in touch.